GLP-1 receptor agonist vs aspirin for primary prevention of colorectal cancer: Evidence from a real-world head-to-head comparison.Colton Jones, Sukeshi Patel Arora, Ariana Neely et al.|Journal of Clinical Oncology|2026Cited by 3